Antithrombin Deficiency

  • James P.  R. BrownEmail author
  • Joanne Douglas


This chapter outlines the pathophysiology, inheritance, and incidence of antithrombin deficiency. The chapter discusses the associated thrombotic risk in pregnancy and the medical and anesthetic management of pregnant women with antithrombin deficiency.


Antithrombin deficiency, Antithrombin III deficiency, Inherited thrombophilia 


  1. 1.
    Kobayashi T. Antithrombin abnormalities and perinatal management. Curr Drug Targets. 2005;6:559–66.CrossRefGoogle Scholar
  2. 2.
    Franchini M, Veneri D, Salvagno G, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci. 2006;43:249–90.CrossRefGoogle Scholar
  3. 3.
    Rheaume M, Weber F, Durand M, Mahone M. Pregnancy-related venous thromboembolism risk in asymptomatic women with antithrombin deficiency. A systematic review. Obstet Gynecol. 2016;127:649–56.CrossRefGoogle Scholar
  4. 4.
    American College of Obstetricians and Gynecologists. Inherited thrombophilias in pregnancy. Practice bulletin no. 138. Obstet Gynecol. 2013;122:706–17.CrossRefGoogle Scholar
  5. 5.
    Rowbottom S. Epidural caesarean section in a patient with congenital antithrombin III deficiency. Anaesth Intens Care. 1995;23:493–5.Google Scholar
  6. 6.
    Pamnani A, Rosenstein M, Darwich A, Wolfson A. Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy. J Clin Anesth. 2010;22:450–3.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.UBC Department of Anesthesiology, Pharmacology and TherapeuticsBC Women’s HospitalVancouverCanada
  2. 2.Department of AnesthesiaBC Women’s HospitalVancouverCanada

Personalised recommendations